TCT-140 Prospective Multicenter Registry of 6 Months Dual Antiplatelet Therapy after new Generation Drug-eluting Stent Implantation: ESTROFA-DAPT Study.

Fernando Riverocrespo,Xavier Carrillo,Antonio Gomez Menchero,Francisco Bosa,Jose Domingo Cascon,Antonio L Arrebola,Federico Gimeno,German Zavala,Leire Andraka,Antonio Ramirez Moreno,Jose L Castillo,Angel Sanchezrecalde,Helena Tizonmarcos,Jose M De La Torre Hernandez,Juan F Oteo Dominguez,Felipe Hernandez,Rocio De Lemos,Omar Abduljawad Altisent

Journal of the American College of Cardiology（2013）

Cited 0|Views14

No score

Abstract

Drug-eluting stents (DES) have been related to a certain risk of late thrombosis. The recommended duration of dual antiplatelet therapy (DAPT) with DES is 12 months. DAPT is not free from complications and is expensive. Trials with limited size suggest that a 6 month DAPT period could be enough with

Translated text

Key words

months dual antiplatelet therapy,drug-eluting drug-eluting stent implantation,stent implantation,antiplatelet therapy,estrofa-dapt

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined